How many years of comparable data are there for Rwanda and Zambia?

39 years are reported by both, from 1980 to 2018.

Where does this data come from?

World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Rwanda vs Zambia: Statin use vs. average non-HDL cholesterol levels

Rwanda

2.6

in 2018

Zambia

2.7

in 2018

Rwanda rank

187th

Zambia rank

184th

Statin use vs. average non-HDL cholesterol levels over time

Rwanda
Zambia

How they compare

Zambia currently reports 2.7 against 2.6 in Rwanda, a difference of 0.1.

Across all 39 years both countries report, Zambia has been ahead every year.

Rwanda ranks 187th and Zambia ranks 184th of 191 countries.

Zambia has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade	Rwanda	Zambia	Difference	Ahead
1980s	2.11	2.69	0.58	Zambia
1990s	2.27	2.7	0.43	Zambia
2000s	2.43	2.7	0.27	Zambia
2010s	2.52	2.7	0.1778	Zambia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher statin use vs. average non-hdl cholesterol levels, Rwanda or Zambia?: Zambia, at 2.7 against 2.6 in Rwanda as of 2018.
What is the difference in statin use vs. average non-hdl cholesterol levels between Rwanda and Zambia?: 0.1, with Zambia ahead.
How many years of comparable data are there for Rwanda and Zambia?: 39 years are reported by both, from 1980 to 2018.
How do Rwanda and Zambia rank globally for statin use vs. average non-hdl cholesterol levels?: Rwanda ranks 187th and Zambia ranks 184th of 191 countries.
Where does this data come from?: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator: Statin use vs. average non-HDL cholesterol levels
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 191 places, 7,449 data points, 1980–2018
Last refreshed: 07 August 2026

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.